Ming Yao

Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Artiklar

Journal article: PLOS ONE. 2025;20(11):e0333356
Optimizing the in vitro production of immunomodulatory cells for the induction of tolerance in solid organ transplantation
Agren N; Yao M; Skantze C; Habibi K; Ericzon B-G; Kumagai-Braesch M
Journal article: TRANSPLANTATION. 2025;109(10S):s48
PS18.2: Immunological characterization of brain-dead donor blood components and their effect on the generation of donor-specific immunomodulatory cells in vitro.
Kumagai-Braesch M; Ågren N; Palau SO; Kuźnicki J; Skinderowicz K; Yao M; Ericzon B-G
Journal article: TRANSPLANTATION. 2025;109(10S):s94
P.57: Ex-vivo-generated immunomodulatory cells reduce proinflammatory macrophage (M1) polarization.
Agren N; Okada K; Alhatour R; Martinez DM; Ajeenah A; Qasha M; Yao M; Ericzon B-G; Kumagai-Braesch M
Journal article: PLOS ONE. 2025;20(6):e0325421
Monolayer whole adherent islets: A novel tool for studying drug-induced diabetic phenotypes in vitro
Kumagai-Braesch M; Yao M; Agren N; Karadagi A; Ericzon B-G; Domogatskaya A
Journal article: CELL TRANSPLANTATION. 2025;34:09636897251382315
Phenotypic and functional comparisons between cryopreserved and freshly isolated peripheral blood mononuclear cells with or without red blood cell lysate (ACK) treatment with special focus on regulatory T cells
Habibi K; Agren N; Okada K; Johansson H; Yao M; Kumagai-Braesch M
Article: CELL TRANSPLANTATION. 2024;33:9636897241256462
Evaluation of Methods to Obtain Peripheral Blood Mononuclear Cells From Deceased Donors for Tolerance-Induction Protocols
Yao M; Henriksson J; Fahlander H; Guisti Coitinho P; Lundgren T; Agren N; Ericzon B-G; Kumagai-Braesch M
Journal article: TRANSPLANTATION. 2022;106(9S):s153-s154
245.2: Evaluation of Methods to Obtain Peripheral Blood Mononuclear Cells From Deceased Donors Adjacent to Organ Procurement for Tolerance-Induction Protocols
Yao M; Henriksson J; Fahlander H; Coitinho PG; Lundgren T; Ågren N; Ericzon B-G; Kumagai-Braesch M
Article: TRANSPLANT INTERNATIONAL. 2021;34(12):2816-2823
Autologous regulatory T cells in clinical intraportal allogenic pancreatic islet transplantation
Bergstrom M; Yao M; Muller M; Korsgren O; Von Zur-Muhlen B; Lundgren T
Article: CELL TRANSPLANTATION. 2021;30:9636897211039739
Cibinetide Protects Isolated Human Islets in a Stressful Environment and Improves Engraftment in the Perspective of Intra Portal Islet Transplantation
Yao M; Domogatskaya A; Agren NI; Watanabe M; Tokodai K; Brines M; Cerami A; Ericzon B-G; Kumagai-Braesch M; Lundgren T
Article: TRANSPLANTATION. 2020;104(10):2048-2058
Improvement of Islet Allograft Function Using Cibinetide, an Innate Repair Receptor Ligand
Yao M; Watanabe M; Sun S; Tokodai K; Cerami A; Brines M; Ostenson C-G; Ericzon B-G; Lundgren T; Kumagai-Braesch M
Article: WORLD JOURNAL OF SURGERY. 2020;44(6):1954-1965
Impact of Hepatic Artery Variations and Reconstructions on the Outcome of Orthotopic Liver Transplantation
Karakoyun R; Romano A; Yao M; Dlugosz R; Ericzon B-G; Nowak G
Article: CELL TRANSPLANTATION. 2018;27(11):1692-1704
Ex Vivo Generation of Donor Antigen-Specific Immunomodulatory Cells A Comparison Study of Anti-CD80/86 mAbs and CTLA4-lg Costimulatory Blockade
Watanabe M; Kumagai-Braesch M; Yao M; Thunberg S; Berglund D; Sellberg F; Jorns C; Enoksson SL; Henriksson J; Lundgren T; Uhlin M; Berglund E; Ericzon B-G
Journal article: JOURNAL OF DIABETES & METABOLISM. 2016;7(10):2-10
An Engineered Innate Repair Receptor Agonist, ARA 290, Protects Rat Islets from Cytokine-induced Apoptosis
Watanabe M; Saito Y; Wallmo J; Takahashi T; Diab RAH; Yao MH; Brines M; Cerami A; Ostenson C-G; Lundgren T; Kumagai-Braesch M

Alla övriga publikationer

Conference publication: TRANSPLANTATION. 2022;106(9):S153-S154
Evaluation of Methods to Obtain Peripheral Blood Mononuclear Cells From Deceased Donors Adjacent to Organ Procurement for Tolerance-Induction Protocols
Yao M; Henriksson J; Fahlander H; Coitinho PG; Lundgren T; Agren N; Ericzon B-G; Kumagai-Braesch M
Doctoral thesis: 2022
Targeting innate and adaptive immune responses to achieve long-term allograft acceptance following transplantation
Yao MH
Conference publication: TRANSPLANTATION. 2018;102:S747-S748
Improvement of Metabolic Function after Intra-Portal Allogeneic Islet Transplantation Using Induction Treatment of the Non-Hematopoetic Erythropoietin Analogue Cibinetide in a Mouse Model
Yao MH; Waatanabe M; Sun S; Tokodai K; Cerami A; Brines M; Ericzon BG; Lundgren T; Kumagai-Braesch M
Meeting abstract: TRANSPLANTATION. 2018;102:S232
Ex-Vivo Generation of Alloantigen-Specific Immunomodulatory Cells: Elucidating the Mechanistical Synergy of Cell Components
Yao MH; Kumagai-Braesch M; Watanabe M; Tokodai K; Lundgren T; Uhlin M; Ericzon BG
Conference publication: AMERICAN JOURNAL OF TRANSPLANTATION. 2018;18:623
Ex-Vivo Generation of Alloantigen-Specific Immunomodulatory Cells: Elucidating the Mechanistical Synergy of Cell Components.
Yao M; Kumagai-Braesch M; Watanabe M; Tokodai K; Lundgren T; Uhlin M; Ericzon B
Conference publication: AMERICAN JOURNAL OF TRANSPLANTATION. 2018;18:252
Improvement of Metabolic Function after Intra-Portal Allogeneic Islet Transplantation by Induction Treatment of the Non-Hematopoetic Erytropoetin Analogue Cibinetide in a Mouse Model.
Yao M; Watanabe M; Sun S; Ericzon B; Lundgren T; Kumagai-Braesch M
Conference publication: AMERICAN JOURNAL OF TRANSPLANTATION. 2017;17:424-425
Cibinetide (ARA 290), the Innate Repair Receptor Ligand, Improves Engraftment in Pancreatic Islet Transplantation by Protecting Islets and Reducing Inflammatory Reactions
Watanabe M; Yao MH; Zemack H; Ericzon B-G; Cerami A; Brines M; Lundgren T; Kumagai-Braesch M
Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2016;46:1063
A Non-hematopoietic erythropoietin analogue, ARA 290, prolonged allogeneic islet graft survival in a mouse model
Watanabe M; Yao MH; Cerami A; Brines M; Ericzon B-G; Lundgren T; Kumagai-Braesch M
Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2016;46:125
Ex vivo generation of alloantigen-specific T regulatory cells using selective T-cell costimulation blockade
Watanabe M; Kumagai-Braesch M; Thunberg S; Henrikson J; Sellberg F; Lundgren T; Yao MH; Jorns C; Berglund D; Berglund E; Ericzon B-G
Conference publication: TRANSPLANTATION. 2016;100(7):S463
Ex vivo generation of alloantigen-specific Immunomodulatory cells with co-stimulation blockade: do we need Treg purification for cell therapy?
Yao MH; Kumagai-Braesch M; Lundgren T; Andersson D; Ericzon B-G; Watanabe M
Conference publication: TRANSPLANTATION. 2016;100(7):S463-S464
A non-hematopoietic erythropoietin analogue, ARA 290, prolonged allogeneic islet graft survival in a mouse model
Watanabe M; Yao MH; Ericzon B-G; Cerami A; Brines M; Lundgren T; Kumagai-Braesch M
Conference publication: TRANSPLANTATION. 2015;99(11):S47
EX VIVO GENERATION OF ALLOANTIGEN-SPECIFIC T REGULATORY CELLS USING SELECTIVE T-CELL CO-STIMULATION BLOCKADE.
Watanabe M; Kumagai-Braesch M; Yao M; Berglund D; Jorns C; Thunberg S; Lind-Enoksson S; Henrikson J; Lundgren T; Sellberg F; Berglund E; Ericzon B-G

Forskningsbidrag

ALF in medicine
Region Stockholm
1 January 2025 - 31 December 2027
Cell-based immunotherapy in solid organ transplantation to minimize systemic immunosuppression
Swedish Research Council
1 January 2019 - 31 December 2021

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI